The role of coronary artery disease in lung transplantation: a propensity-matched analysis
CONCLUSION: In this cohort, relevant CAD was not associated with worse outcomes and should therefore not be considered a contraindication for LuTx. Nonetheless, cardiovascular events in CAD patients highlight the necessity of control of cardiovascular risk factors and a structured cardiac follow-up.PMID:38587564 | DOI:10.1007/s00392-024-02445-y
Source: Clin Med Res - Category: Research Authors: Enzo L üsebrink Nils Gade Paula Seifert Felix Ceelen Tobias Veit Fabian Fohrer Sabine Hoffmann Julia H öpler Leonhard Binzenh öfer Daniel Roden Inas Saleh Hugo Lanz Sebastian Michel Christian Schneider Michael Irlbeck Roland Tomasi Rudolf Hatz J örg H Source Type: research
More News: Angioplasty | Bilirubin | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Heart Attack | Lung Transplant | Percutaneous Coronary Intervention | Research | Statistics | Stroke | Transplant Surgery | Transplants